About this Journal
Aims and scope
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.
Subject areas include (but are by no means limited to):
- Acute coronary syndrome
- Basic cardiac electrophysiology
- Cardiac catheterization
- Cardiac remodeling
- Coagulation and thrombosis
- Diabetic cardiovascular disease
- Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
- Ischemic heart disease
- Vascular biology
- Ventricular assist devices
- Molecular cardio-biology
- Myocardial regeneration
- Lipoprotein metabolism
- Radial artery access
- Percutaneous coronary intervention
- Transcatheter aortic and mitral valve replacement
The Wiley Hindawi Partnership
This journal is published by Hindawi as part of a publishing collaboration with John Wiley & Sons, Inc. It is a fully Open Access journal produced under the Hindawi and Wiley brands.
ISSN: 1755-5914 (Print)
ISSN: 1755-5922 (Online)
Content published prior to 2019 is hosted on the Wiley Online Library.
Editorial enquiries should be directed to firstname.lastname@example.org.